These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16389313)

  • 1. Genetic mouse models of parkinsonism: strengths and limitations.
    Fleming SM; Fernagut PO; Chesselet MF
    NeuroRx; 2005 Jul; 2(3):495-503. PubMed ID: 16389313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors involved in the pathogenesis of Parkinson's disease.
    Lee FJ; Liu F
    Brain Res Rev; 2008 Aug; 58(2):354-64. PubMed ID: 18313759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism?
    Alves da Costa C; Checler F
    Cell Signal; 2011 Jun; 23(6):963-8. PubMed ID: 20969953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From genes to proteins in mendelian Parkinson's disease: an overview.
    Pirkevi C; Lesage S; Brice A; Başak AN
    Anat Rec (Hoboken); 2009 Dec; 292(12):1893-901. PubMed ID: 19943343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Function study advances of Parkinson disease related genes].
    Wang XM; Wang DQ; Wang XY
    Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paths to neurodegeneration in genetic Parkinson's disease.
    Abdel-Salam OM
    CNS Neurol Disord Drug Targets; 2014; 13(9):1485-512. PubMed ID: 25106632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetics of Parkinson's disease].
    Toda T
    Brain Nerve; 2007 Aug; 59(8):815-23. PubMed ID: 17713117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
    Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
    Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
    Yamashita H; Matsumoto M
    Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Song B; Feldmann JW; Cao S; Feitosa M; Kong Y; Kim W; Schweitzer A; Leblanc P; Schweitzer JS; Kim KS
    Neurobiol Dis; 2022 Aug; 170():105777. PubMed ID: 35636646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism.
    Fleming SM; Chesselet MF
    Behav Pharmacol; 2006 Sep; 17(5-6):383-91. PubMed ID: 16940759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the genetic studies in Parkinson's disease].
    Krygowska-Wajs A; Wszolek Z
    Neurol Neurochir Pol; 2004; 38(2):127-36. PubMed ID: 15307606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.
    Barzilai A; Melamed E
    Trends Mol Med; 2003 Mar; 9(3):126-32. PubMed ID: 12657434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic rodent models of Parkinson's disease.
    Harvey BK; Wang Y; Hoffer BJ
    Acta Neurochir Suppl; 2008; 101():89-92. PubMed ID: 18642640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing in Parkinson's disease.
    McInerney-Leo A; Hadley DW; Gwinn-Hardy K; Hardy J
    Mov Disord; 2005 Jan; 20(1):1-10. PubMed ID: 15503301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.